Stay informed with the latest litigation news. Explore now

IP Verse

Injection Device - EP3187219B1

EP3187219

ALLERGAN
Application Number
EP17155371A
Filing Date
Dec 2, 2009
Status
Granted And Under Opposition
Mar 20, 2020
Grant Date
Apr 22, 2020
External Links
Slate, Register, Google Patents
Similar Patents facing opposition
EP2442821B2
EP3509559B8
EP2877138B1

Bibliography

The patent EP3187219B1 was granted to Allergan on Apr 22, 2020 following the initial filing on Dec 2, 2009 under the application number EP17155371A . The current legal status of the patent is Granted And Under Opposition.

Patent Summary

Patent Family New

Patent Family

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateOpposition Status

Get instant alerts for new oppositions and patent status changes

MERZ PHARMAJan 22, 2021 -

Dossier Documents

The dossier documents provide a comprehensive record of the patent’s prosecution history, including filings, correspondence, and decisions made by patent offices. These documents are crucial for understanding the patent’s legal journey and any challenges it may have faced during examination. It also includes the oppositions documents filed against the patent.

  • Date

    Description

  • Get instant alerts for new documents